Vaxart director receives new stock and option awards

Vaxart director Kevin Finney reported equity awards dated July 16, 2026.

Rhea-AI Filing Summary

Vaxart director Kevin Finney reported equity awards dated July 16, 2026. He received 39,400 shares of Common Stock upon vesting of restricted stock units, bringing his direct holdings to 244,171 shares. He was also granted 78,700 stock options with a $0.5149 exercise price, expiring July 16, 2036. Both the RSU shares and options vest on the earlier of the date immediately prior to Vaxart’s 2027 annual meeting of stockholders and July 16, 2027, the first anniversary of the grant.

Insider Trade Summary

Grant/Award: 118,100 shares

Grant/Award 2 txns

Insider Finney Kevin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (right to buy) F2	78,700	$0.00	$0.00
Grant/Award	Common Stock F1	39,400	$0.00	$0.00

Holdings After Transaction: Stock Options (right to buy) — 78,700 contracts (Direct); Common Stock — 244,171 shares (Direct)

Footnotes (2)

1. F1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.
2. F2. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.

Key Figures

RSU shares vested: 39,400 shares of Common Stock Shares held after award: 244,171 shares of Common Stock Stock options granted: 78,700 options +3 more

6 metrics

RSU shares vested 39,400 shares of Common Stock Grant of shares upon vesting of restricted stock units on July 16, 2026

Shares held after award 244,171 shares of Common Stock Direct holdings following RSU share grant

Stock options granted 78,700 options Stock Options (right to buy) granted on July 16, 2026

Option exercise price $0.5149 per share Conversion or exercise price for 78,700 stock options

Option expiration July 16, 2036 Expiration date of the 78,700 stock options

Vesting date outer limit July 16, 2027 First anniversary of grant; latest vesting date for RSUs and options

Key Terms

restricted stock units, Stock Options (right to buy, vest, annual meeting of stockholders

4 terms

restricted stock units financial

"Grant of shares upon vesting of restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Options (right to buy financial

"Stock Options (right to buy) granted for 78,700 shares."

vest financial

"The shares underlying the award shall vest on the earlier of the date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"earlier of the date immediately prior of the 2027 annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Kevin Finney report for Vaxart (VXRT) on July 16, 2026?

Kevin Finney reported two equity awards: 39,400 newly vested shares of Common Stock and 78,700 stock options. The awards are part of his director compensation and follow specified vesting conditions tied to Vaxart’s 2027 annual meeting and the grant’s first anniversary.

How many Vaxart (VXRT) shares does Kevin Finney hold after the latest Form 4 filing?

After the reported award, Kevin Finney directly holds 244,171 shares of Vaxart Common Stock. This total reflects the addition of 39,400 shares received upon vesting of restricted stock units granted as part of his service as a director.

What stock options did Kevin Finney receive from Vaxart (VXRT) and at what exercise price?

Kevin Finney received 78,700 stock options to buy Vaxart Common Stock at an exercise price of $0.5149 per share. These options represent additional potential ownership, subject to vesting conditions and exercisable before their stated expiration date in 2036.

When do Kevin Finney’s new Vaxart (VXRT) RSU shares and options vest?

Both the RSU shares and options vest on the earlier of (1) the date immediately prior to Vaxart’s 2027 annual meeting of stockholders and (2) July 16, 2027, which is the first anniversary of the grant date.

What is the expiration date of Kevin Finney’s newly granted Vaxart (VXRT) stock options?

The newly granted stock options to Kevin Finney expire on July 16, 2036. He may exercise up to 78,700 options at $0.5149 per share, provided the options have vested under the stated 2027 vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Finney Kevin

(Last) (First) (Middle)

C/O VAXART, INC.

310 UTAH AVENUE, SUITE 150

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		39,400(1)	A	$0	244,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	$0.5149	07/16/2026		A		78,700		(2)	07/16/2036	Common Stock	78,700	$0	78,700	D

Explanation of Responses:

1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.

2. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.

	/s/ Edward Berg, Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)